Revenue: The sum of all revenue fields included for a company's operating activities.
Beta Bionics, Inc. (BBNX) had Revenue of $27.63M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$27.63M |
$-21.89M |
|
$11.19M |
|
$16.44M |
|
$51.90M |
|
$-24.27M |
|
$2.38M |
|
$-21.89M |
|
$-21.89M |
|
$-21.89M |
|
$-21.89M |
|
$-21.89M |
|
$-21.89M |
|
$-24.27M |
|
$-23.28M |
|
44.44M |
|
44.44M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$247.99M |
|
$10.16M |
|
$56.43M |
|
$304.42M |
|
$23.19M |
|
-- |
|
$9.98M |
|
$33.17M |
|
$271.25M |
|
$271.25M |
|
$271.25M |
|
44.56M |
|
| Cash Flow Statement Financials | |
$-23.83M |
|
$21.84M |
|
$0.62M |
|
$31.68M |
|
$30.31M |
|
$-1.37M |
|
$5.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
59.50% |
|
-87.86% |
|
-87.86% |
|
-- |
|
-79.26% |
|
-79.26% |
|
$-25.21M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.47 |
|
1.75 |
|
51.31 |
|
-8.07% |
|
-8.07% |
|
-7.19% |
|
-8.07% |
|
$6.09 |
|
$-0.57 |
|
$-0.54 |
|